Stockscreener 앱 받기
14.65
0.00%
0.00
전일 마감가:
$14.65
열려 있는:
$14.65
하루 거래량:
635.06K
Relative Volume:
0.81
시가총액:
$435.81M
수익:
$30.43M
순이익/손실:
$-18.15M
주가수익비율:
-21.23
EPS:
-0.69
순현금흐름:
$-9.08M
1주 성능:
-1.81%
1개월 성능:
+6.01%
6개월 성능:
+29.30%
1년 성능:
-2.07%
1일 변동 폭
$14.30
$15.09
1주일 범위
$13.80
$15.77
52주 변동 폭
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
CLPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
14.65 | 435.81M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
Published on: 2026-01-16 07:23:49 - baoquankhu1.vn
Precision Trading with Clearpoint Neuro, Inc. (CLPT) Risk Zones - Stock Traders Daily
ClearPoint Neuro (NASDAQ:CLPT) CEO Sells $322,400.00 in Stock - MarketBeat
Earnings Risk: Will ClearPoint Neuro Inc stock deliver better than expected guidance2025 Valuation Update & Long-Term Growth Portfolio Plans - Bộ Nội Vụ
ClearPoint Neuro reports 20% sales growth in Q4 2025 By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) Reports Strong Preliminary Revenue Growt - GuruFocus
CLPT Forecasts Strong Revenue Growth by 2026 - GuruFocus
ClearPoint Neuro sees Q4 revenue $10.4M, up 20% y/y - TipRanks
ClearPoint Neuro (CLPT) Reports Strong Q4 2025 Revenue Growth - GuruFocus
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue - morningsun.net
ClearPoint Neuro prelim Q4 revenue rises - TradingView — Track All Markets
How ClearPoint Neuro Inc. stock benefits from tech adoption2025 Top Decliners & High Return Trade Opportunity Guides - Улправда
Is ClearPoint Neuro Inc. stock attractive after correctionJuly 2025 Trade Ideas & Weekly High Conviction Ideas - Улправда
ClearPoint Neuro restructures IRRAS subsidiary under debt agreement - MSN
Will ClearPoint Neuro Inc. stock attract ESG investors2025 Analyst Calls & Fast Gaining Stock Reports - ulpravda.ru
ClearPoint Neuro enters consent agreement related to IRRAS AB reorganization - Investing.com Australia
ClearPoint Neuro Restructures IRRAS Subsidiary Under Debt Agreement - TipRanks
ClearPoint Neuro Signs Consent to Note Purchase Agreement With Oberland Capital - TradingView — Track All Markets
Technical Reactions to CLPT Trends in Macro Strategies - Stock Traders Daily
ClearPoint Neuro enters consent agreement related to IRRAS AB reorganization By Investing.com - Investing.com Nigeria
Published on: 2025-12-27 12:00:42 - bollywoodhelpline.com
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a Potential 100% Upside in the Healthcare Sector - DirectorsTalk Interviews
What Creates a Long-Term Growth Opportunity for ClearPoint Neuro (CLPT)? - Insider Monkey
(CLPT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
What analysts say about ClearPoint Neuro Inc stockEquity Performance Review & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet? - 富途牛牛
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Analyst Calls: How strong is AMTD IDEA Group Depositary Receipt stock balance sheetJuly 2025 Decliners & AI Forecast Swing Trade Picks - moha.gov.vn
retail investors who own 51% along with institutions invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) saw increase in their holdings value last week - simplywall.st
Is ClearPoint Neuro Inc. stock supported by innovation pipelinePortfolio Performance Summary & Daily Chart Pattern Signal Reports - Улправда
How ClearPoint Neuro Inc. stock valuations compare to rivalsJuly 2025 Recap & Fast Moving Stock Trade Plans - Улправда
Kenai Advances Allogeneic Stem Cell Therapy for Parkinson’s - San Diego Business Journal
Behavioral Patterns of CLPT and Institutional Flows - Stock Traders Daily
ClearPoint Neuro Announces Merger with IRRAS Holdings - MSN
Latham & Watkins Advises IRRAS on Acquisition by ClearPoint Neuro - Latham & Watkins LLP
Trend Review: Will ClearPoint Neuro Inc. stock outperform Nasdaq index2025 Market WrapUp & Weekly Setup with ROI Potential - moha.gov.vn
Geode Capital Management LLC Buys 323,429 Shares of ClearPoint Neuro, Inc. $CLPT - MarketBeat
Here’s What Boosted ClearPoint Neuro (CLPT) in Q3 - Insider Monkey
Can ClearPoint Neuro Inc. stock withstand economic slowdownMarket Sentiment Review & Free Safe Entry Trade Signal Reports - Newser
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
Is ClearPoint Neuro Inc. stock positioned well for digital economyPortfolio Risk Summary & Daily Entry Point Alerts - Newser
ClearPoint Neuro (CLPT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will ClearPoint Neuro Inc. stock maintain dividend yieldJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - Newser
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):